Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 29, 2007
Diabetes Care 30:2369-2373, 2007
DOI: 10.2337/dc07-0649
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0649v1
30/9/2369    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banks, W. A.
Right arrow Articles by Morley, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banks, W. A.
Right arrow Articles by Morley, J. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

Insulin Resistance Syndrome in the Elderly

Assessment of functional, biochemical, metabolic, and inflammatory status

William A. Banks, MD1,2, Lisa M. Willoughby, PHD3, David R. Thomas, MD2 and John E. Morley, MB, BCH1,2

1 Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center, St. Louis, Missouri
2 Division of Geriatrics, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, Missouri
3 Center for Outcomes Research, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, Missouri

Address correspondence and reprint requests to William A. Banks, MD, 915 N. Grand Blvd., St. Louis, MO 63106. E-mail: bankswa{at}slu.edu

OBJECTIVE—Hyperinsulinemic euglycemia, or insulin resistance syndrome (IRS), is associated with increased morbidity and mortality. Although thought to be associated with proinflammatory states, little work has been done in this area. Here, we determined the impact of IRS on functional, biochemical, metabolic, and inflammatory status in a high-risk population: elderly women in nursing homes.

RESEARCH DESIGN AND METHODS—Functional, biochemical, metabolic, and inflammatory parameters were measured in 100 consecutive ambulatory, elderly women who resided in nursing homes. Diabetic subjects and residents with fasting blood glucose ≥110 mg/dl were excluded. Remaining residents were classified as insulin resistant (IR) (insulin >100 pmol/l) or non-IR (NIR).

RESULTS—A total of 16 residents were IR and 53 NIR. No differences in functional status, BMI, renal function, C-reactive protein, or immune cell levels were found. Fasting blood glucose was higher in IR subjects ([means ± SD] 94.1 ± 8.1 vs. 87.9 ± 8.2, P < 0.05), indicating a very mild glucose intolerance. Serum C-peptide (P < 0.05), amylin (P < 0.01), and leptin (P < 0.01), but not adiponectin or resistin, were higher in IR subjects. Higher leptin-to-BMI and insulin–to–C-peptide ratios suggested an increased percent body fat mass and altered clearance of insulin, respectively. Eleven of 13 cytokines had arithmetic elevations, but only tumor necrosis factor-{alpha} (TNF) reached statistical significance (P < 0.01). TNF and insulin levels were highly correlated.

CONCLUSIONS—IRS in the healthiest of long-term care residents is relatively rare but is associated with mild glucose intolerance, increased percent body fat, altered insulin clearance, and a proinflammatory status as evidenced by an elevated TNF.

Abbreviations: IL, interleukin • IR, insulin resistant • IRS, insulin resistance syndrome • MAP, macrophage inflammatory protein • NIR, non–insulin resistant • RANTES, regulated on activation, normal T-cell expressed and secreted • TNF, tumor necrosis factor


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Cohen, D. Ilic, J. Raupachova, and W. H. Horl
Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes
J. Immunol., September 15, 2008; 181(6): 3761 - 3768.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. S. Singhal, R. T. Patel, Y. Qi, Y.-S. Lee, and R. S. Ahima
Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E331 - E338.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.